https://www.taxtmi.com/caselaws?id=197960 In a patent infringement suit seeking ad interim injunction, full disclosure of the complete specification, relevant x-ray diffraction data, and pending related applications was required to establish a prima facie case; non-disclosure of material particulars defeated interim relief. The Court treated section 3(d) of the Patents Act, 1970 as an anti-evergreening provision for pharmaceutical inventions and found a credible challenge where enhanced efficacy and novelty were seriously in issue, making the patent vulnerable at the interlocutory stage. Public interest in access to an affordable life-saving medicine was also relevant and, on the balance of equities, justified refusal of interim injunction. en-us Fri, 24 Apr 2009 00:00:00 +0530 Thu, 18 Jan 2018 18:09:36 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=197960 In a patent infringement suit seeking ad interim injunction, full disclosure of the complete specification, relevant x-ray diffraction data, and pending related applications was required to establish a prima facie case; non-disclosure of material particulars defeated interim relief. The Court treated section 3(d) of the Patents Act, 1970 as an anti-evergreening provision for pharmaceutical inventions and found a credible challenge where enhanced efficacy and novelty were seriously in issue, making the patent vulnerable at the interlocutory stage. Public interest in access to an affordable life-saving medicine was also relevant and, on the balance of equities, justified refusal of interim injunction. Case-Laws Companies Law Fri, 24 Apr 2009 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=197960